Marshall H. Woodworth
Director of Finance/CFO at NEUROBO PHARMACEUTICALS, INC.
Net worth: 102 498 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hyung-Heon Kim | M | 47 | 3 years | |
| Andrew Koven | M | 66 | 3 years | |
| D. Strickland | M | 77 | 2 years | |
| Mark Glickman | M | 58 | 1 years | |
| Michael Salsbury | M | 74 | 5 years | |
| Jason Groves | M | 52 | 5 years | |
| James Tursi | M | 59 | 1 years | |
| Caroline Andersson | F | - | 9 years | |
| Erling Lennart Johansson | M | 69 | 9 years | |
| Eduardo Fracasso | M | 64 | 16 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| June Almenoff | M | 67 | 4 years | |
| Scott Myers | M | 57 | 4 years | |
| Wendy Dixon | M | 68 | 4 years | |
| Stephen R. Light | M | 77 | 4 years | |
| Sriram J. Ramanathan | M | - |
Nevakar, Inc.
 Nevakar, Inc. Pharmaceuticals: MajorHealth Technology Nevakar, Inc. is a specialty injectable pharmaceutical company focused on developing innovative products in injectable and ophthalmic space. The company was founded by Navneet Puri in 2015 and is headquartered in Bridgewater, NJ. | 6 years |
| Sailash I. Patel | M | - | - | |
| Michael Colérus | M | 62 | 15 years | |
| Staffan Lindstrand | M | 62 | 15 years | |
| J. Milner | M | 63 | 4 years | |
| Joseph J. Gurandiano | M | 78 | 10 years | |
| Stephen W. Kaldor | M | 62 | 4 years | |
| Thomas Gutierrez | M | 75 | 6 years | |
| David G. Maffucci | M | 73 | 2 years | |
| Stephen Davis | M | 63 | 1 years | |
| Paul S. Covington | M | 68 | - | |
| Stuart O. Bondurant | M | 94 | - | |
| Peter Corr | M | 76 | 4 years | |
| Joan Badrinas Ardèvol | M | 70 | 7 years | |
| Jonathan Young | M | 54 |
Braeburn Pharmaceuticals SPRL
 Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | 2 years |
| Hans Henrik Jacobson | M | 51 | 2 years | |
| Ken Marshall | M | - | - | |
| Morten Pedersen | M | - | - | |
| Jay Powers | M | 62 | 5 years | |
| Maria Strömme | M | 54 | 1 years | |
| John B. Saunders | M | 81 | 4 years | |
| John G. Raos | M | 75 | 2 years | |
| Gail McIntyre | M | 61 | 4 years | |
| Henrik Bergentoft | M | 50 | 2 years | |
| Donald P. Aiken | M | 80 | 4 years | |
| Nico Hansen | M | 55 | 2 years | |
| John S. Thompson | M | 76 | 4 years | |
| Miguel Quiñonez | M | 77 | 7 years | |
| Cheryl A. Diuguid | F | 73 | 3 years | |
| Anders Murman | M | 57 | - | |
| Peter Williamson | M | 57 | 4 years | |
| Bruce Stevens | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 34 | 73.91% |
| Sweden | 11 | 23.91% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marshall H. Woodworth
- Personal Network
